The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key territories has introduced significant risk . Investors are now grappling with the impact of rival medications , s